November 18, 2021
November 18, 2021 – The U.S. FDA is expanding a black box warning, the most prominent warning that can be required on a drug label, for Bayer's Climara
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
GlobalReach Health
November 15, 2021
November 15, 2021 – Mvasi® (bevacizumab-awwb) has received a new indication to treat epithelial ovarian, fallopian tube, or primary peritoneal cancer. The drug, manufactured by Amgen
November 15, 2021
November 15, 2021 – The U.S. FDA has approved a new indication for Ruxience® (rituximab-pvvr), Pfizer's biosimilar for Genentech and Biogen’s Rituxan® (rituximab)
November 15, 2021
November 15, 2021 – PharmaEssentia's Besremi® (ropeginterferon alfa-2b-njft) has been approved to treat polycythemia vera (PV) in adults. It is the only interferon drug FDA approved
November 8, 2021
November 8, 2021 – EprontiaTM (topiramate) 25mg/mL oral solution has received U.S. FDA approval to treat seizures and prevent migraines in children and adults.
November 5, 2021
November 5, 2021 – A new dosage form of Dyanavel XR® (amphetamine) has received U.S. FDA approval to treat attention deficit hyperactivity disorder (ADHD) in patients who are at
November 3, 2021
November 3, 2021 – The Advisory Committee on Immunization Practices (ACIP) for the U.S. Centers for Disease Control and Prevention (CDC) now recommends hepatitis B
November 1, 2021
November 1, 2021 – ANI Pharmaceuticals has announced U.S. FDA approval of the company’s Purified CortrophinTM Gel (repository corticotropin injection). The product is indicated to treat